Alwin Krämer
Impact in
- Hematology top 0.2%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Cell Biology top 0.5%
- Microtubule and mitosis dynamics
Papers in
- Hematology 91
- Acute Myeloid Leukemia Research 79
- Multiple Myeloma Research and Treatments 7
- Hematopoietic Stem Cell Transplantation 3
- Cell Biology 34
- Microtubule and mitosis dynamics 34
- Co-authors
- Jiri Bartek (10 shared papers)Claudia Lukas (2 shared papers)Zuzana Hořejšı́ (1 shared paper)Karsten Zieger (1 shared paper)Karen Koed (1 shared paper)Torben Falck Orntoft (1 shared paper)Per Guldberg (1 shared paper)Jiřina Bártková (1 shared paper)
- Journals
- Blood (31 papers)Leukemia (7 papers)International Journal of Cancer (7 papers)Journal of Clinical Oncology (6 papers)Cancer Research (6 papers)
- Partner nations
- GermanyUnited StatesDenmark
In The Last Decade
Alwin Krämer
182 papers receiving 10.5k citations
Alwin Krämer's Hit Papers
Peers
Comparison fields: 5 of 125
- Hematology 3.8k
- Cell Biology 1.4k
- Oncology 1.5k
- Cancer Research 580
- Genetics 323
Countries citing papers authored by Alwin Krämer
This map shows the geographic impact of Alwin Krämer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alwin Krämer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alwin Krämer more than expected).
Fields of papers citing papers by Alwin Krämer
This network shows the impact of papers produced by Alwin Krämer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alwin Krämer. The network helps show where Alwin Krämer may publish in the future.
Co-authors
The 25 scholars most cited alongside Alwin Krämer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 191 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis Hit paper breakdown → | 2005 | 2284 |
| 2 | Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease Hit paper breakdown → | 2010 | 671 |
| 3 | Prediction of acute myeloid leukaemia risk in healthy individuals Hit paper breakdown → | 2018 | 669 |
| 4 | Quizartinib versus salvage chemotherapy in relapsed or refractory FLT3-ITD acute myeloid leukaemia (QuANTUM-R): a multicentre, randomised, controlled, open-label, phase 3 trial Hit paper breakdown → | 2019 | 387 |
| 5 | Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial Hit paper breakdown → | 2015 | 350 |
| 6 | Measurable residual disease-guided treatment with azacitidine to prevent haematological relapse in patients with myelodysplastic syndrome and acute myeloid leukaemia (RELAZA2): an open-label, multicentre, phase 2 trial Hit paper breakdown → | 2018 | 282 |
| 7 | 2013 | 278 | |
| 8 | 2004 | 272 | |
| 9 | 2018 | 222 | |
| 10 | 2014 | 206 | |
| 11 | 2010 | 155 | |
| 12 | 2007 | 154 | |
| 13 | 2012 | 153 | |
| 14 | 2014 | 141 | |
| 15 | 2020 | 114 | |
| 16 | 2021 | 112 | |
| 17 | 2020 | 100 | |
| 18 | 2011 | 99 | |
| 19 | 2011 | 91 | |
| 20 | 2006 | 89 |
About Alwin Krämer
Alwin Krämer is a scholar working on Hematology, Cell Biology, Oncology, Pathology and Forensic Medicine and Genetics, having authored 191 papers that have together received 10.7k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (79 papers), Microtubule and mitosis dynamics (34 papers), Cancer Diagnosis and Treatment (33 papers), Multiple Myeloma Research and Treatments (7 papers), Cancer-related Molecular Pathways (7 papers), Lymphoma Diagnosis and Treatment (5 papers), DNA Repair Mechanisms (4 papers) and Hematopoietic Stem Cell Transplantation (3 papers). The work is most often cited by research in Hematology (3.8k citations), Cell Biology (1.4k citations), Oncology (1.5k citations), Cancer Research (580 citations) and Genetics (323 citations). Alwin Krämer has collaborated with scholars based in Germany, United States and Denmark. Frequent co-authors include Jiri Bartek, Claudia Lukas, Zuzana Hořejšı́, Karsten Zieger, Karen Koed, Torben Falck Orntoft, Per Guldberg, Jiřina Bártková, Frederic Tort and Jahn Martin Nesland. Their work appears in journals such as Blood, Leukemia, International Journal of Cancer, Journal of Clinical Oncology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.